Sanofi, MSD successfully terminate vaccines JV
Sanofi Pasteur and MSD have now completed the takedown of their vaccines joint venture Sanofi Pasteur MSD, ending a collaboration that has spanned more than two decades.
Read More
Tag: Sanofi Pasteur MSD
- Strong clinical data for Breye lead asset danegaptide
- EHP Awards triumph
- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
